Experimental vaccine for common cancer shows potential in clinical trial A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care. Original Source: https://www.foxnews.com/health/experimental-vaccine-common-cancer-shows-potential-clinical-trial
